Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men

Journal of Lipid Research

Volumn 38, Issue 4, 1997, Pages 795-804

  Hoffstedt, Johan ^a   Arner, Peter ^a   Hellers, Göran ^a   Lönnqvist, Fredrik ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

adrenoceptors; adrenergic receptors; lipolysis; omental adipocytes; subcutaneous adipocytes

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BRIMONIDINE; CATECHOLAMINE; DOBUTAMINE; NORADRENALIN; TERBUTALINE;

ADIPOCYTE; ADULT; ARTICLE; BIOPSY; BODY MASS; CELL SUSPENSION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPID ANALYSIS; LIPOLYSIS; MALE; OBESITY; OMENTUM; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; SUBCUTANEOUS FAT;

ADIPOCYTES; ADIPOSE TISSUE; ADRENERGIC AGONISTS; ADULT; BIOPSY; DOBUTAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIPOLYSIS; MALE; MIDDLE AGED; NOREPINEPHRINE; OBESITY; OMENTUM; PROPANOLAMINES; QUINOXALINES; RECEPTORS, ADRENERGIC; SKIN; TERBUTALINE;

EID: 0030896519     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lafontan, M., and M. Berlan. 1993. Fat cell adrenergic receptors and the control of white and brown fat cell function. J. Lipid Res. 34: 1057-1092.
2. Leibel, R. L., N. K. Edens, and K. Fried. 1989. Physiologic basis for the control of body fat distribution in humans. Annu. Rev. Nutr. 9: 417-443.
3. Kissebah, A. H. 1991. Insulin resistance in visceral obesity. Int. J. Obes. 15: 109-115.
4. Abate, N., and A. Garg. 1995. Heterogeneity in adipose tissue metabolism: causes, implications and management of regional adiposity. Prog. Lipid Res. 34: 53-70.
5. Arner, P. 1995. Difference in lipolysis between human subcutaneous and omental adipose tissue. Ann. Med. 27: 435-438.
6. Frayn, K. N., C. M. Williams, and P. Arner. 1996. Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases? Clin. Sci. 90: 243-253.
7. 2-adrenoceptors. Diabetologia. 37: 428-435.
8. Arner, P., H. Wahrenberg, F. Lönnqvist, and B. Angelin. 1993. Adipocyte β-adrenoceptor sensitivity influences plasma lipid levels. Arterioscler. Thromb. 13: 967-972.
9. Reynisdottir, S., K. Ellerfeldt, H. Wahrenberg, H. Lithell, and P. Arner. 1994. Multiple lipolysis defects in the insulin resistance (metabolic) syndrome. J. Clin. Invest. 93: 2590-2599.
10. Mauriège, P., J. P. Desprès, D. Prud'homme, M. C. Pouliot, M. Marcotte, A. Tremblay, and C. Bouchard 1991. Regional variation in adipose tissue lipolysis in lean and obese men. J. Lipid Res. 32: 1625-1633.
11. 3-adrenoceptors in obesity. J. Clin. Invest. 95: 1109-1116.
12. 3-adrenoceptor sensitivity in visceral adipose tissue. Diabetologia. 39: 838-844.
13. Mauriège, P., A. Marette, C. Atgié, C. Bouchard, G. Thériault, L. K. Bukowiecki, P. Marceau, S. Biron, A. Nadeau, and J. P. Després. 1995. Regional variation in adipose tissue metabolism of severely obese premenopausal women. J. Lipid Res. 36: 672-684.
14. Rodbell, M. 1964. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J. Biol. Chem. 239: 375-380.
15. Di Girolamo, M., S. Mendlinger, and J. W. Fertig. 1971. A simple method to determine fat cell size and number in four mammalian species. Am. J. Physiol. 221: 850-858.
16. Hirsch, J., and E. Gallian. 1968. Methods for determination of adipose cell size and number in man and animals. J. Lipid Res. 9: 110-119.
17. Arner, P., J. Bolinder, J. Hellmér, and P. Engfeldt. 1986. Studies on human fat cell metabolism in small adipose tissue samples. In Methods in Diabetes Research. Vol. 2. W. L. Clarke, J. Lamer, and S. L. Pohl, editors. John Wiley and Sons, Chichester. 234-258.
18. 3HCGP-12177, generally classified as an antagonist, is a thermogenic agonist in brown adipose tissue. Biochem. J. 261: 401-405.
19. 2-agonist for the characterization of alpha-adrenoceptor subtypes. Eur. J. Pharmacol. 72: 413-415.
20. Lönnqvist, F., and P. Arner. 1989. Interaction between adenylate cyclase inhibitors and β-adrenoceptors in isolated human fat cells. Biochem. Biophys. Res. Commun. 161: 654-660.
21. Marcus, C., B. Karpe, P. Bolme, T. Sonnenfeldt, and P. Arner. 1987. Changes in catecholamine-induced lipolysis in isolated human fat cells during the first year of life. J. Clin. Invest. 79: 1812-1818.
22. Lönnqvist, F., A. Wennlund, and P. Arner. 1989. Antilipolytic effects of insulin and adenylate cyclase inhibitors on isolated human fat cells. Int. J. Obes. 13: 137-146.
23. Hellmér, J., P. Arner, and A. Lundin. 1989. Automatic luminometric kinetic assay of glycerol for lipolysis studies. Anal. Biochem. 177: 132-137.
24. Kenakin, T. 1984. The classification of drugs and drug receptors in isolated tissue. Pharmacol. Rev. 36: 165-214.
25. Goldstein, A., L. Arronow, and S. M. Kalman. 1974. Principles of Drug Action: the Basis of Pharmacology (1,2). John Wiley and Sons, New York. 82-111.
26. 3-adrenoceptor agonists on lipolysis in human omental adipocytes. Int. J. Obes. 20: 428-434.
27. Hellmér, J., C. Marcus, T. Sonnenfeld, and P. Arner. 1992. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells. J. Clin. Endocrinol. Metab. 75: 15-20.
28. Kissebah, A. H., N. Vydelingum, R. Murray, D. J. Evans, A. J. Hartz, R. K. Kalkhoff, and P. W. Adams. 1982. Relation of body fat distribution to metabolic complications of obesity. J. Endocrinol. Metab. 54: 254-260.
29. Jacobsson, B., and U. Smith. 1972. Effect of fat cell size on lipolysis and antilipolytic action of insulin in human fat cells. J. Lipid Res. 13: 651-656.
30. Arner, P. 1996. Regulation of lipolysis in human fat cells. Diabetes Rev. 4: 1-13.